Friday 6 November 2026 Export JNJ’s income statement to Excel — free account

Johnson & Johnson

JNJ Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024.

Revenue: +5.86%
EPS: −95.8%
Free cash flow: −21.4%
Total debt: −9.16%

Quarter to September 2026, against a year earlier

272.44 3.88 −1.40%

Follow JNJ

Alert me

Market cap: $655.6B
P/E: 41.3×
Fwd P/E: 40.0×
Dividend yield: 1.94%
F-score: 3/9
Altman Z: 4.78
Beneish M: −2.26
Dividend safety: 78/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	40.11	29.43	28.26	18.73	+8 more quarters Free account
P/S ratio Full definition →	6.42	6.24	6.11	5.29
P/FCF ratio Full definition →	30.39	26.91	32.26	24.40
P/Operating CF Full definition →	82.63	70.96	234.20	68.16
P/B ratio Full definition →	7.82	7.20	7.25	6.11
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	6.61	6.41	6.27	5.49
EV/EBITDA Full definition →	23.71	18.01	17.43	12.29
EV/Operating CF Full definition →	25.10	22.75	26.42	21.10
EV/FCF Full definition →	31.28	27.64	33.10	25.35
Quick Ratio Full definition →	0.65	0.73	0.69	0.69
Current Ratio Full definition →	1.02	1.09	1.03	1.03
Net Debt/EBITDA Full definition →	7.27	1.80	1.82	2.60
Debt/Assets Full definition →	18.13%	18.57%	18.68%	19.80%
Debt/Equity Full definition →	0.44	0.44	0.46	0.48
Asset Turnover Full definition →	0.51	0.50	0.49	0.50
Operating CF/Net income Full definition →	36.76	1.56	0.48	1.43
Capex/Depreciation Full definition →	(0.65)	(0.64)	(0.51)	(0.76)
Interest Coverage Full definition →	2.01	25.79	23.86	25.31
Research and Development Expense of Revenue Full definition →	18.32%	14.43%	14.66%	17.31%
Selling, General and Administrative Expense of Revenue Full definition →	24.75%	25.41%	25.08%	27.49%
Intangible Assets out of Total Assets Full definition →	0.48	0.48	0.49	0.50
Share Based Compensation of Revenue Full definition →	1.41%	1.81%	1.25%	1.26%
Graham Net Nets Full definition →	(0.09)	(0.09)	(0.10)	(0.12)
Graham Number Full definition →	70.88	82.79	80.99	91.77
Earnings Yield Full definition →	2.49%	3.40%	3.54%	5.34%
Free Cash Flow Yield Full definition →	3.29%	3.72%	3.10%	4.10%
Revenue per Share Full definition →	10.54	10.51	9.99	10.20
Operating CF per Share Full definition →	3.20	3.58	1.04	3.04
Capex per Share Full definition →	(0.57)	(0.52)	(0.42)	(0.63)
Free Cash Flow per Share Full definition →	2.64	3.06	0.62	2.40
Cash per Share Full definition →	7.15	8.62	9.15	8.35
Shareholders Equity per Share Full definition →	33.84	35.30	33.71	33.87
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	33.84	35.30	33.71	33.87
Free Cash Flow Full definition →	6,354.00	7,358.00	1,494.00	5,784.00
Working Capital Full definition →	894.00	4,879.00	1,457.00	1,498.00
Capital Expenditures Full definition →	(1,366.00)	(1,258.00)	(1,020.00)	(1,525.00)
Net Current Asset Value Full definition →	(59,545.00)	(56,316.00)	(60,535.00)	(62,042.00)
EV/EBIT Full definition →	33.51	23.16	22.44	14.95
Capex to Sales Full definition →	0.05	0.05	0.04	0.06
Price to Operating Income Full definition →	35.97	24.27	23.61	15.29
Other line items
Average Receivables Full definition →	18,299.00	18,446.00	16,870.50	16,010.00
Average Payables Full definition →	9,471.00	9,343.50	10,002.50	11,151.00
Average Inventory Full definition →	14,761.50	14,278.00	13,621.00	13,317.50
Average Assets Full definition →	195,120.50	197,225.00	197,282.50	189,657.00
Average Common Equity Full definition →	80,403.00	81,722.00	79,647.50	76,517.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly